Zhang, S., Ji, Q., Wang, Q., Hu, S. (2025). Prophylactic rituximab administered on day -1 during conditioning significantly reduces early EBV reactivation in pediatric allogeneic HSCT: Real-world evidence from a propensity-matched cohort of 834 patients. Blood. https://doi.org/10.1182/blood-2025-5988